47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | -1,6 | -2,2 | -38,4 |
EBITDA | -1,4 | -1,8 | -28,8 |
Short time liabilities | 2,1 | 6 | 185 |
Equity capital | -1,6 | -3,7 | -138,6 |
Operating profit (EBIT) | -1,5 | -2 | -35 |
Assets | 3,5 | 8,6 | 144,1 |
Net profit (loss) | -1,6 | -2,2 | -38,4 |
Cash | 0,5 | 1,3 | 180,1 |
Net income from sale | 1,7 | 11,9 | 603,2 |
Liabilities and provisions for liabilities | 5,1 | 12,3 | 142,4 |
Working assets | 2,4 | 6,5 | 173,8 |
Depreciation | 0 | 0,1 | 245,5 |
% | % | p.p. | |
Profitability of capital | 100,1 | 58,1 | -42 |
Equity capital to total assets | -44,3 | -43,4 | 0,9 |
Gross profit margin | -92 | -18,1 | 73,9 |
EBITDA Margin | -83,5 | -15,3 | 68,2 |
Days | Days | Days | |
Short term commitment turnover cycle | 456 | 185 | -271 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane